Related content

Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats

By Holma R.   Salmenpera P.   Riutta A.   Virtanen I.   Korpela R.   Vapaatalo H.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 309-318

Elsevier

Access to resources Recommend Favorite

The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C 4 in the guinea-pig ileum

By Back M.   Jonsson E.W.   Dahlen S.-E.  

European Journal of Pharmacology, Vol. 317, Iss. 1, 1996-12 ,pp. : 107-113

Elsevier

Access to resources Recommend Favorite

Protective mechanisms of resveratrol against methotrexate‐induced renal damage may involve BCRP/ABCG2

By  

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 406-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic effects of pranlukast and a leukotriene B 4 receptor antagonist on antigen-induced pulmonary reaction

By Sakurada T.   Abe M.   Kodani M.   Sakata N.   Katsuragi T.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 153-159

Elsevier

Access to resources Recommend Favorite

Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity

By Ibrahim Mohamed A.   El-Sheikh Azza A. K.   Khalaf Hanaa M.   Abdelrahman Aly M.  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 130-137

Informa Healthcare

Access to resources Recommend Favorite